beta-lactams has been researched along with Drug Abuse, Intravenous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almela, M; Brugal, MT; Castro, P; Caylà, JA; Coll, P; Colomés, JLL; de la Red, G; de Olalla, PG; Español, M; García, F; Gatell, JM; Libois, A; March, F; Romeu, J; Salvadó, M; Sambeat, MA; Sánchez, F; Sierra, JM; Vila, J | 1 |
Berger-Bächi, B; Ender, M; McCallum, N | 1 |
2 other study(ies) available for beta-lactams and Drug Abuse, Intravenous
Article | Year |
---|---|
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Molecular Epidemiology; Mutation; Population Surveillance; Prospective Studies; Restriction Mapping; Retrospective Studies; Risk Factors; Sequence Analysis, DNA; Soft Tissue Infections; Spain; Streptococcal Infections; Streptococcus pyogenes; Substance Abuse, Intravenous | 2006 |
Impact of mecA promoter mutations on mecA expression and beta-lactam resistance levels.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactams; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin-Binding Proteins; Point Mutation; Promoter Regions, Genetic; Sequence Alignment; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Switzerland | 2008 |